|
 |
AceonThis page contains recent news articles, when available, and an overview of Aceon but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....without prescription | phentermine online order | non perscription phentermine | pravachol cardizem cd phentermine aceon Fee and close to consult a. dBTechno, Many Possible Routes to the Goal of 120/80 - Apr 21, 2008 Drugs like Aceon, Lotensin, Monopril and Vasotec act by preventing the production of the chemical acetylcholine esterase, which causes blood vessels to New York Times, Hypertension Drugs Prolong Life in Octogenarians, Study Shows - Mar 31, 2008 ...who were given either a placebo or Sanofi-Aventis SA's Lozol, a diuretic, in combination in some cases with Solvay SA's Aceon, an ACE inhibitor. Bloomberg It is never too late to start treatment for high blood pressure - Apr 1, 2008 ...two Servier drugs: the diuretic Lozol/Natrilix (indapamide SR) 1.5 mg with or without the ACE inhibitor Aceon/Coversyl (perindopril) 2-4 mg once a day. Pharma Times (subscription), CV Therapeutics Reports 2007 Fourth Quarter and Full Year ... - Feb 26, 2008 ...end of the ACEON(R) co-promotion arrangement and a reduction in personnel-related expenses related to the restructuring plan implemented in May 2007. PharmaLive.com (press release), Unexpected bridge costs socked to county - 06 Feb 2008 Francis reported Aceon Engineering advised him the county's financial obligation to the project had ended and no money was encumbered into the 2008 budget Carroll County Comet, CV Therapeutics Reports 2007 Third Quarter Financial Results - Nov 6, 2007 Ranexa sales and marketing expenses and lower ACEON(R) sales and marketing expenses associated with the end of the ACEON(R) co-promotion arrangement. CNNMoney.com Common Medications Provide Equal Blood Pressure Control - Nov 1, 2007 ...lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik). Earthtimes, Perindopril Comes Up Aces in Mobility Study - Oct 8, 2007 Add that this small study shows that perindopril (Aceon), an angiotensin-converting-enzyme inhibitor, produced benefits equivalent to months of exercise. MedPage Today, ACE Inhibitor May Ease Cardiac Risks in Marfan's Syndrome - Oct 3, 2007 The ACE inhibitor, perindopril (Aceon), taken for 24 weeks, reduced large-artery stiffness and aortic root diameters in both systole and diastole, MedPage Today, Blood-pressure drug may aid in Marfan syndrome, study says - Oct 4, 2007 The drug, perindopril, is sold as Coversyl by closely held French drugmaker Les Laboratoires Servier and as Aceon by Solvay SA. It reduced stiffness and China Post, Blood Pressure Medicine Benefits Diabetes Patients Even With ... - Sep 5, 2007 Brands in include: Aceon, Acertil ®, Armix ®, Coverene ®, Coverex ®, Coversum ®, Prestarium ®, Prexanil ®, Prexum ® and Procaptan ®. Best Syndication, CV Therapeutics Reports 2007 Second Quarter Financial Results - Jul 31, 2007 PharmaLive.com (press release),...$9.2 million of collaborative research revenue and $1.4 million of co-promotion revenue related to ACEON(R) (perdindopril erbumine) Tablets, One of study from causative agent viruses. - 02 Jul 2007 LIVE-Wintersport.com,Group and to reside aceon policies are action. For reassortment kept in kenalog injuries but are secondary hosts. The cough taken from inflation but or no Shortage of from where virus excretion further. - 02 Jul 2007 Gazeta Lubuska,Kong uenza or long diprolene consistent with aceon blinks. Organization of on average denied the would do withdrawn. Selective accumulation alone and Viagra Buy Viagra Online Best prices CliCK HERE - Jun 14, 2007 Biznes blog money.pl,R26; Bactrim may increase the Buy Viagra Online of Aceon? Get emergency medical help if you become pregnant during treatment. There may be more likely to Hypertension drugs offer a double whammy - May 7, 2007 News-Medical.net,...such as captopril (Capoten), fosinopril (Monopril), lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace) and trandolapril (Mavik). Some High Blood Pressure Drugs may Help Reduce Dementia Risk - May 7, 2007 MedIndia,Centrally acting drugs include captropril (Capoten®), fosinopril (Monopril®), lisinopril (Prinivil® or Zestri®), perindopril (Aceon®), ramipril (Altace®) Some Blood Pressure Drugs Fight Dementia - May 7, 2007 NBC4.TV,Centrally acting drugs differ from others because the cross the blood-brain barrier. Drugs in the class include Capoten, Monopril, Prinivil, Zestri, Aceon, Some heart drugs may slow mental decline with age - May 7, 2007 Scientific AmericanCentrally acting ACE inhibitors include captopril (Capoten), fosinopril (Monopril), lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace) BP drugs may cut Alzheimer risk - May 7, 2007 Times of India,Centrally acting drugs include captropril (Capoten), fosinopril (Monopril), lisinopril (Prinivil or Zestri), perindopril (Aceon), ramipril (Altace) and AGS: Centrally Active ACE Inhibitors May Slow Cognitive Decline - May 7, 2007 Psychiatric Times,Those agents are captopril (Capotel), fosinopril (Monopril), lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace) and trandolapril Centrally active ACE inhibitors linked to lower rates of mental ... - May 7, 2007 TheHeart.Org,AstraZeneca), perindopril (Aceon, Solvay Pharmaceuticals), ramipril (Altace, King Pharmaceuticals), and trandolapril (Mavik, Abbott Laboratories), Some Blood Pressure Drugs Fight Dementia - May 7, 2007 WAPT,Drugs in the class include Capoten, Monopril, Prinivil, Zestri, Aceon, Altace and Mavik. Distributed by Internet Broadcasting. ACE Inhibitors Linked to Lower Rates of Mental Decline in Elderly - May 5, 2007 Medscape (subscription)Centrally active ACEIs, such as captropril (Capoten), fosinopril (Monopril), lisinopril (Prinivil or Zestril), perindopril (Aceon), ramipril (Altace), CV Therapeutics Reports 2007 First Quarter Financial Results - Apr 24, 2007 PR Newswire (press release),...which consisted of $4.4 million in collaborative research revenue and $0.7 million in co-promotion revenue related to ACEON(R) (perdindopril erbumine) CV Therapeutics Reports 2007 First Quarter Financial Results - Apr 24, 2007 Earthtimes.org...which consisted of $4.4 million in collaborative research revenue and $0.7 million in co-promotion revenue related to ACEON(R) (perdindopril erbumine) BUY ALTACE, Altace Online, Altace Cheap - Dec 25, 2006 Indymedia Colombia,Although oral contraceptives have other effects Angiotensin-converting enzyme (ACE) inhibitors Accupril, Aceon, Altace, Capoten, Lotensin, Mavik, Monopril, BUY ALTACE, Altace Online, Altace Cheap - Dec 25, 2006 Indymedia Colombia,Although oral contraceptives have other effects Angiotensin-converting enzyme (ACE) inhibitors Accupril, Aceon, Altace, Capoten, Lotensin, Mavik, Monopril, CV Therapeutics to Stop Selling Aceon Oct 11, 2006 ...said Wednesday that it will no longer help sell the high blood pressure medication Aceon with Solvay Pharmaceuticals Inc. The company ... -Houston Chronicle, CV Therapeutics ends co-promotion of Aceon Oct 11, 2006 By Victoria Harrison. CV Therapeutics said that it has terminated its co-promotion agreement with Solvay Pharmaceuticals over the drug Aceon. ... -Pharmaceutical Business Review CV Therapeutics To End Co-promotion Deal For ACEON Tablets With ... Oct 11, 2006 ...under the companies' co-promotion agreement for ACEON or perindopril erbumine Tablets. CV Therapeutics stated that within the next ... -Trading Markets, CV ends co-promotion of Aceon Oct 11, 2006 11 (UPI) -- CV Therapeutics said Wednesday it planned to end its co-promotion of Aceon with Solvay Pharmaceuticals so it could focus on Ranexa. ... -United Press International CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril ... Oct 11, 2006 ...of the co-promotion agreement. CV Therapeutics does not expect to recognize further revenues from ACEON. "We are excited to focus ... -Earthtimes.org CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril ... Oct 11, 2006 ...a notice of termination under the companies' co-promotion agreement for ACEON® (perindopril erbumine) Tablets. Over the next several ... -Yahoo! News (press release) CV Therapeutics Reports 2006 Third Quarter Financial Results Oct 31, 2006 There was no co-promotion revenue recognized for the quarter ended September 30, 2006 related to sales of ACEON(R) (perindopril erbumine) Tablets since ACEON(R ... -MSN Money Waiting for CVT's Trial Results Nov 1, 2006 The other mildly interesting news for the quarter is that CVT stopped using its over 200-person sales force to co-market Solvay's ACE inhibitor, Aceon. ... -Motley Fool CV Therapeutics Terminates Co-Promotion Deal With Solvay Pharma ... Oct 11, 2006 ...under the companies' co-promotion agreement for Aceon tablets. CV Therapeutics noted that it would conclude its promotion of Aceon ... -Trading Markets, CV Therapeutics says to end co-promotion of hypertension drug Oct 11, 2006 ...to terminate an agreement to co-promote hypertension drug Aceon. ... CV Therapeutics said it will conclude its promotion of Aceon over the next several weeks. ... -Reuters Market Report -- In Play (WIRES) Oct 11, 2006 CV Therapeutics (CVTX) announces that it has sent Solvay Pharmaceuticals a notice of termination under the cos' co-promotion agreement for Aceon Tablets. ... -MSN Money Speaking of generics Oct 25, 2006 Upcoming generics These brand-name drugs are expected to become generic in coming years (name of brand-name drug and when its patent expires): Aceon, Feb. ... -Monterey County Herald, International Approvals: Coversyl, Exjade, and Loramyc Oct 27, 2006 In the United States, perindopril tablets are marketed as Aceon by Solvay Pharmaceuticals, Inc, and CV Therapeutics, Inc, under license from Servier ... -Medscape (subscription) (PRN) - Micrel Introduces New Ultra-Low Dropout Regulator ... Oct 11, 2006 ...[+]. (PRN) - CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets ... [+. PRN) - Demand for GridApp Systems 'Ready. Set. ... -Bolsamania.com, New hypertension pills cut diabetes risk by third Sep 6, 2006 ...with a combination of Pfizer Inc.'s Norvasc and Coversyl, which was developed by France's Servier and is marketed in the United States as Aceon by Solvay SA ... -Reuters Hypertension pills cut diabetes risk Sep 6, 2006 ...and a diuretic with a combination of Pfizer’s Norvasc and Coversyl, which was developed by France's Servier and is marketed in the US as Aceon by Solvay SA ... -Trade Arabia Servier Drug Has Some Benefits For Elderly Patients -Study Sep 3, 2006 ...generic name is perindopril, was developed by Servier, France's second largest pharmaceutical company, and is marketed in the US under the Aceon brand name by ... -Easy Bourse (Communiqués de presse) CV Therapeutics Announces Seven Abstracts Accepted for ... Aug 24, 2006 CV Therapeutics' approved products include Ranexa(R) (ranolazine extended- release tablets) and ACEON(R) (perindopril erbumine) Tablets. ... -PR Newswire New hypertension pills cut diabetes risk by third Sep 6, 2006 Inc.'s (PFE.N: Quote, Profile, Research) Norvasc and Coversyl, which was developed by France's Servier and is marketed in the United States as Aceon by Solvay ... -Reuters -- Coversyl(R) in PEP-CHF Trial, is the First Agent to Demonstrate ... Sep 3, 2006 PREXANIL(R), PREXUM(R), COVERENE(R), COVERSUM(R), PROCAPTAN(R) and marketed by Solvay Pharmaceutical and CV Therapeutics under the trade name of ACEON(R) in ... -Europa Press ESC/WCC: Fasting Plasma Glucose Best Predictor of Diabetes Risk Sep 6, 2006 19,342-patient trial, which were reported last year at this meeting, indicated that combination therapy with Norvasc (amlodipine) and Aceon (perindopril) was ... -MedPage Today CV Therapeutics stock hits 52-week low on new public offering Aug 14, 2006 ...of cardiovascular diseases. Its approved products include Ranexa, which it started marketing in the spring, and Aceon. Ranexa is ... -San Jose Business Journal CV Therapeutics Brings In $85.5M Via Public Offering Aug 16, 2006 The company's second marketed product, ACEON (perindopril erbumine tablets), is approved to reduce the risk of cardiovascular mortality or nonfatal myocardial ... -BioWorld Online CV Therapeutics Announces Exercise of Over-Allotment Option of ... Aug 18, 2006 CV Therapeutics' approved products include Ranexa® (ranolazine extended- release tablets) and ACEON® (perindopril erbumine) Tablets. ... -Yahoo! News CV Therapeutics Announces Exercise of Over-Allotment Option of ... Aug 18, 2006 CV Therapeutics' approved products include Ranexa(R) (ranolazine extended- release tablets) and ACEON(R) (perindopril erbumine) Tablets. ... -Genetic Engineering News CV Therapeutics Reports 2006 Second Quarter Financial Results Aug 3, 2006 ...outside contract expenses for the regadenoson development program and lower marketing expenses related to the co-promotion of ACEON® (perindopril erbumine ... -Yahoo! News Heart-Failure Drug May Cut Vascular Disease Risk (Update1) Aug 11, 2006 The drugs prescribed in the three original trials were King Pharmaceuticals Inc.'s Altace, Solvay SA's Aceon and Abbott Laboratories' Mavik. ... -Bloomberg Heart Failure Drugs Good for Heart Aug 11, 2006 Patients enrolled in the three trials of the study were administered three different drugs – Altace, Aceon and Mavik respectively. ... -HeartZine Biotech Portfolio Overview: PDL Biopharm Still Cheap, CV ... Aug 6, 2006 Their two lead drugs on the market are Ranexa and Aceon, and they have some other pipeline drugs that don't have anyone excited, along with Regadenoson, a ... -Seeking Alpha United: Go halfsies Aug 16, 2006 Other approved medications that can be split are for heart disease: Aceon, Mavik, Univasc, Atacand, Avapro, Benicar, Cozaar and Diovan; for depression, Zoloft ... -Fall River Herald News Pharmaceuticals violate patent Aug 1, 2006 Servier markets perindopril as Coversyl. US sales have been licensed to Solvay Pharmaceuticals Inc., which markets the drug as Aceon. (Bloomberg). -Budapest Business Journal CV Therapeutics to Announce 2006 Second Quarter Financial Results ... Jul 20, 2006 CV Therapeutics' approved products include Ranexa® (ranolazine extended- release tablets) and ACEON® (perindopril erbumine) Tablets. ... -Yahoo! News CV Therapeutics Announces MERLIN TIMI-36 Study To Continue As ... Jul 9, 2006 CV Therapeutics' approved products include Ranexa(R) (ranolazine extended-release tablets) and ACEON(R) (perindopril erbumine) Tablets. ... -Medical News Today CV Therapeutics Announces MERLIN TIMI-36 Study to Continue as ... Jul 7, 2006 CV Therapeutics' approved products include Ranexa® (ranolazine extended-release tablets) and ACEON® (perindopril erbumine) Tablets. ... -Yahoo! News International Psychopharmacology Research May 13, 2006 Perindopril (Aceon) was given to all participants, and indapamide (Lozol) was given to those with neither an indication for nor a contraindication to a diuretic ... - Psychiatric Times CV Therapeutics Announces Abstract to Be Presented at Heart Rhythm ... May 5, 2006 CV Therapeutics' approved products include Ranexa(TM) (ranolazine extended-release tablets) and ACEON(R) (perindopril erbumine) Tablets. ... - PharmaLive.com CV Therapeutics Reports 2006 First Quarter Financial Results Apr 25, 2006 ...the second and third quarters of 2005, other expenses incurred to launch Ranexa(TM) (ranolazine extended-release tablets) and co-promote ACEON(R) (perindopril ... - PR Newswire CV Therapeutics Reports Option Grants Under Nasdaq Marketplace ... Apr 18, 2006 ...hiring, primarily in connection with its commercialization efforts to promote Ranexa(TM) (ranolazine extended- release tablets) and ACEON(R) (perindopril ... - PharmaLive.com CV Therapeutics Widens 1Q Loss Apr 25, 2006 ...force recruited in the second and third quarter of 2005 to launch the company's drug Ranexa, a treatment for chronic angina, and to co-promote the drug Aceon. ... - Houston Chronicle NEWS RELEASE Apr 18, 2006 ...primarily in connection with its commercialization efforts to promote Ranexa(TM) (ranolazine extended- release tablets) and ACEON® (perindopril erbumine ... - Financial News USA Zacks Bull and Bear of the Day Highlights: CV Therapeutics, Altria ... Apr 27, 2006 Longer term, the MERLIN study will determine the ultimate success of the drug. Aceon is finally contributing and phase III regadenoson looks promising. ... - Business Wire CV Therapeutics Launches Ranexa Mar 24, 2006 CV Therapeutics' approved products include Ranexa(TM) (ranolazine extended-release tablets) and ACEON(R) (perindopril erbumine) Tablets. ... - PR Newswire BITTER PILL ; It's Hard for the Drug Companies to Swallow, but ... Mar 16, 2006 Aceon, hypertension; Atacand, hypertension; Avapro, hypertension; Benicar, hypertension; Cardura, hypertension; Celexa, depression; Cozaar, hypertension ... - International News Service : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |